H.B. Fuller (FUL) Could Be 27% Undervalued Following Its $850 Million Notes Offering

H.B. Fuller (FUL) has moved its balance sheet into focus after pricing an $850 million private offering of 7.625% senior unsecured notes due 2034, tied closely to its planned AMS acquisition.

Recent trading tells a cooler story. H.B. Fuller’s share price has eased 1.3% over the past week and is down 3.9% over 30 days, while the 90-day share price return has declined 11.6% and the 1-year total shareholder return is lower by 11.8%. This points to fading momentum as investors weigh higher interest costs, activist pressure around a potential Building Adhesive Solutions sale, and the planned AMS acquisition-funded debt raise.

Scan how H.B. Fuller’s debt funded AMS pivot compares with other balance-sheet focused opportunities by reviewing the hand picked list of solid balance sheet and fundamentals (25 results) in similar and adjacent sectors.

After a sharp debt-funded pivot and a share price that has slipped into the high $40s, does it make more sense to step into H.B. Fuller now, or wait for a cleaner entry after the AMS play and activism dust settle?

Most Popular Narrative: 27% Undervalued

The most followed narrative puts H.B. Fuller’s fair value at $68.29, well above the last close at $49.56. This frames the current weakness as a valuation gap rather than just sentiment fatigue.

The company's initiatives to optimize the portfolio mix and streamline the manufacturing cost structure continue through Project Quantum Leap and the SAP rollout. The targeted reduction in plants and roughly US$75m of annual conversion cost savings by 2030 are aimed at lifting EBITDA margins toward and potentially above the 20% goal and supporting earnings quality.

See why 2 investors see H.B. Fuller as 27% undervalued.

Result: Fair Value of $68.29 (UNDERVALUED)

Still, the H.B. Fuller story can break if AMS driven leverage around 4x drags on cash flow, or if volume softness means pricing no longer covers weaker demand.

Find out about the key risks to this H.B. Fuller narrative.

Next Steps

Mixed views on whether H.B. Fuller is an opportunity or a value trap at this point in the AMS story. Act quickly by stress testing the thesis yourself, weighing both the concerns and the upside signposts in the 6 key rewards and 1 important warning sign.

Looking for more H.B. Fuller style investment ideas?

Do not stop with H.B. Fuller. Broaden your watchlist now with a few focused stock shortlists that match different risk, income, and valuation preferences.

• Target potential mispricings by scanning companies flagged as strong value opportunities in the 29 high quality undervalued stocks.
• Strengthen your income stream by reviewing businesses highlighted for robust payouts in the 8 dividend fortresses.
• Dial down portfolio risk by filtering for financially resilient candidates in the 31 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com